A Broken System, New Strategies, and Predicting the

In this ISSUE

Making the Most of Maturing Oncology Brands

Dollars and Digital: The Future of Pharma Finance

Predicting the Future of European Health Policy

Real-World Data

A Broken System – Making Drug Decisions without Real-World Data

The price of a drug need not be, and in fact must not be, the only factor considered when determining its value, writes William Kirsh.
... /Read more/

Advertisement
	Deloitte's 2019 Life Sciences accounting and financial reporting update Insights on new accounting standards and more A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment. Download the full report here

Opinion

Use of High-Efficacy Therapies in MS

Opinion remains divided regarding how aggressively MS should be treated. Some neurologists believe in the "treat early, treat aggressively" approach, whilst others prefer to "save" HE therapies until the more traditional platform therapies have failed.
... /Read more/

AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
On Demand

Learn More

Calendar

/ Nurse Educator Programs – 6/18 /

/ Patient Support Services Congress – 6/19–6/20 /

/ DIA Global Annual Meeting – 6/23–6/27 /

/ Commercial Contract & Chargeback Excellence – 6/25–6/26 /

/ Leadership for Drug Development Teams – 7/8–7/9 /

Pricing in Therapeutic Specific Areas

New Strategies Sought to Pay for Costly Cures

Cell and gene therapies in crosshairs of pricing focus, prompting stepped-up proposals on ways to finance these products.
... /Read more/

FDA Regulatory Affairs

FDA: Advancing Non-Prescription Medicines, Including CBD Products

Jill Wechsler looks at the proposed new FDA rules to beef up regulatory resources and promote digital technologies to support the development and marketing of safe and innovative over-the-counter therapies.
... /Read more/

Change Your Behaviors, Change Your Health & Wellness

The Pharm Exec Podcast: Episode 32

European Editor Julian Upton, speaks with Johnson & Johnson's Jennifer Turgiss, VP Behavior Science & Advanced Analytics group. In their interview, Turgiss discusses behavioral strategies to the health and wellness solutions being developed at J&J.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com